Jing Liu

Jing Liu's work experience includes the following roles and positions:

1. Vice President, Technical Operations at XinThera Inc. (March 2022 - Present)

2. Executive Director / Senior Director / Director, CMC at Turning Point Therapeutics (November 2017 - March 2022)

- Founding member of Turning Point's CMC department.

- Head of the Drug Substance team.

- Served as interim CMC department head overseeing DS, DP, analytical, and supply chain activities.

3. Scientist III, Associate Manager, CMC/Process Chemistry at Dart NeuroScience LLC (April 2013 - November 2017)

- Led multiple projects from lead nomination to Phase I/II stages as the lead process chemist and CMC project manager.

- Provided key strategic and scientific leadership for the process chemistry group.

- Managed multiple PhD-level direct reports and mentored all group members.

4. Senior Scientist, Scale-Up Chemistry at Janssen, Pharmaceutical Companies of Johnson and Johnson (August 2003 - April 2013)

Jing Liu's education history begins at Peking University, where they earned their Bachelor's degree in Chemistry from 1994 to 1998. Jing then pursued higher education at the University of Illinois Urbana-Champaign, where they attained a Doctor of Philosophy (Ph.D.) in Chemistry from 1998 to 2003.

In addition to their formal education, Jing Liu also obtained certification in Duolingo French Fluency: Advanced (Estimated) from Duolingo in October 2015.